Table 2.
Validation assays of proteins in diabetic foot or in burn victims and their potential to discriminate NH from RH (pg/mL).
| Proteins | Patients with diabetic foot | Burn victims | |||
|---|---|---|---|---|---|
| Plasma | Exudate | Exudate | |||
| RH (n = 49) | NH (n = 36) | RH (n = 49) | NH (n = 36) | RH (n = 30) | |
| MCP-2 | 2308.95 (1767.06–2263.37) | 2083.21 ± 70.22†# | 3192.30 (2548.00–3776.81) | 2789.33 ± 165.25†# | 3457.49 ± 99.84& |
| ENA-78 | 1331.00 ± 35.67 | 1134.42 (1077.42–1230.90)†## | 1841.49 ± 54.93 | 1390.43 ± 26.14## | 1755.36 (1555.67–1925.87)†&& |
Data are shown as mean ± SEM, median (interquartile range) of subjects in each group. Differences between the groups were analyzed using †Mann-Whitney U test; the others were analyzed using t-tests. #P < 0.05 or ##P < 0.001 versus RH. &P < 0.05 or &&P < 0.001 versus NH (exudate).